Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000100

Director acquired 4,216 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. Director 2023-06-01 Grant or award +4,216 147,218 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. Director 2023-06-01 Grant or award · Stock Option (right to buy) +12,649 12,649 D: show line 2 in the form
Loading xslF345X04/wk-form4_1686002853.xml…